# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Basal cell carcinoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 48 results.
A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma
Status: Recruiting
Last Changed: Nov 26, 2018
First Received: Oct 22, 2018
Disease(s): Basal Cell Carcinoma
Intervention(s): PD-L1
Locations: Herlev and Gentofte Hospital, Hellerup, Hovedstaden, Denmark
RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell Carcinoma
Status: Recruiting
Last Changed: Jul 10, 2019
First Received: Nov 06, 2017
Disease(s): Basal Cell Carcinoma
Intervention(s): Reflectance Confocal Microscopy
Locations: Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom
Nivolumab Alone or Plus Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
Status: Recruiting
Last Changed: Jun 10, 2019
First Received: May 10, 2018
Disease(s): Basal Cell Carcinoma
Intervention(s): Nivolumab, Ipilimumab
Locations: Johns Hopkins Hospital, Baltimore, Maryland, United States
The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.
Status: Recruiting
Last Changed: Dec 03, 2019
First Received: Sep 18, 2019
Disease(s): Basal Cell Carcinoma
Intervention(s): individualized risk assessment
Locations: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Status: Not yet recruiting
Last Changed: Nov 07, 2019
First Received: Nov 07, 2019
Disease(s): Recurrent Basal Cell Carcinoma
Intervention(s): Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle
Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity and Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Aug 24, 2018
Disease(s): Basal Cell Carcinoma
Intervention(s): Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing MNA, 100 µg doxorubicin-containing MNA, 200 µg doxorubicin-containing MNA
Locations: University of Colorado, Denver, Colorado, United States
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
Status: Recruiting
Last Changed: Dec 03, 2019
First Received: Jun 29, 2018
Disease(s): Superficial Basal Cell Carcinoma
Intervention(s): Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT), Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
Locations: Medical Dermatology Specialists, Phoenix, Arizona, United States
First OC Dermatology, Fountain Valley, California, United States
Cosmetic Laser Dermatology, San Diego, California, United States
AboutSkin Research, LLC, Greenwood Village, Colorado, United States
Center for Clinical and Cosmetic Research, Aventura, Florida, United States
... and 11 other locations.
(Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)
Status: Recruiting
Last Changed: May 10, 2019
First Received: Feb 20, 2019
Disease(s): Basal Cell Carcinoma, Optical Coherence Tomography
Intervention(s): Optical Coherence Tomography
Locations: Maastricht UMC+, Maastricht, Limburg, Netherlands
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer
Status: Recruiting
Last Changed: Dec 05, 2019
First Received: Jun 08, 2017
Disease(s): Skin Basal Cell Carcinoma
Intervention(s): Remetinostat
Locations: Stanford University, School of Medicine, Palo Alto, California, United States
Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Status: Not yet recruiting
Last Changed: Apr 26, 2019
First Received: Mar 04, 2016
Disease(s): Skin Basal Cell Carcinoma
Intervention(s): Arsenic Trioxide, Itraconazole, Laboratory Biomarker Analysis
Locations: Stanford Cancer Institute, Palo Alto, California, United States